Three new radiopharmacy devices have been added to GE Medical Systems' line of Tracerlab chemistry synthesis products. The products, unveiled Oct. 24 at the Academy of Molecular Imaging conference, are used to generate positron-emitting
Three new radiopharmacy devices have been added to GE Medical Systems' line of Tracerlab chemistry synthesis products. The products, unveiled Oct. 24 at the Academy of Molecular Imaging conference, are used to generate positron-emitting radiopharmaceuticals. The Tracerlab FXFDopa, Tracerlab FXF-E, and Tracerlab FXF-N synthesize targeted F-18 radiopharmaceuticals for molecular imaging research. The devices are compatible with all commercially available cyclotrons, according to the company.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.